FdaApplication
ANDA 220511
Identifiers
- fda_app_no: ANDA220511
Properties
| Property | Value |
|---|---|
| applicant_name | AJANTA PHARMA LTD |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 12.5MG/1000MG | TABLET, EXTENDED RELEASE |
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 10MG/1000MG | TABLET, EXTENDED RELEASE |
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 5MG/1000MG | TABLET, EXTENDED RELEASE |
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 25MG/1000MG | TABLET, EXTENDED RELEASE |
4 products